Skip to content

Health— page 17

health

Trump seeks to bring health-research funding under his control, Politico reports

Sept 19 (Reuters) – U.S. President Donald Trump is seeking to bring a major part of national funding for health research under the control of his political appointees, Politico reported on Saturday. Trump has directed his budget director, Russ Vought, to draft an executive order to create a board th

· SRN Health
Trump seeks to bring health-research funding under his control, Politico reports
health

Italy sees mosquitos spread the West Nile virus farther and longer as Europe warms

ROME (AP) — Italian health authorities see evidence that rising temperatures and longer warm seasons are helping mosquitoes spread West Nile virus across a wider area, during more months of the year. More than 650 infections have been reported in Italy so far this year, accounting for roughly half o

· SRN Health
Italy sees mosquitos spread the West Nile virus farther and longer as Europe warms
health

Two hospital systems settle US probe over transgender care billing for $9.5 million

By Steve Gorman Sept 18 (Reuters) – Two major US hospital systems have agreed to pay nearly $9.5 million combined to settle a US Department of Justice probe into claims that the medical centers were improperly billing for gender-affirming care provided to minors, the department said on Friday. Under

· SRN Health
Two hospital systems settle US probe over transgender care billing for $9.5 million
health

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues

Sept 18 (Reuters) – Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public offerings on Friday, reinforcing the biotech pipeline for the fall IPO window. The listings would be the latest in a string of biotech IPOs this year, which analysts say has been

· SRN Health
health

Trump says he will demand some childhood vaccines be split into five shots

Sept 18 (Reuters) – US President Donald Trump said on Friday that his administration plans to demand vaccine makers split certain childhood shots into five separate doses, which he believes will result in a massive reduction in autism, an idea repeatedly debunked by scientists. Trump did not provide

· SRN Health
Trump says he will demand some childhood vaccines be split into five shots
health

Exclusive-Kennedy names new chair for US autism advisory panel

By Ahmed Aboulenein WASHINGTON, Sept 18 (Reuters) – US Health Secretary Robert F. Kennedy Jr. named an ally, Dr. John Gaitanis, to lead a key federal advisory panel on autism on Friday, replacing a chair who had just steered through a new strategic plan, a health department spokesperson told Reuters

· SRN Health
Exclusive-Kennedy names new chair for US autism advisory panel
health

US FDA approves Lilly’s breast cancer drug combo

Sept 18 (Reuters) – The US FDA has approved Eli Lilly’s drug combination to treat adults with a type of advanced breast cancer that has spread to other parts of the body, the drugmaker said on Friday. Here are some details: • The combination, Inluriyo-Verzenio, is meant for patients whose tumors are

· SRN Health
US FDA approves Lilly’s breast cancer drug combo
health

Suspected alcohol poisoning kills 49 in Nigeria’s Ondo state

LAGOS, Sept 18 (Reuters) – At least 49 people have died and 182 others were hospitalised after suspected alcohol poisoning in Nigeria’s southwestern Ondo state, the state’s health commissioner said on Friday. • The health emergency was first reported on September 5 with authorities saying 29 people

· SRN Health
health

Galderma mindful of focus while eyeing product range expansion, CEO tells FuW

Sept 18 (Reuters) – Galderma’s CEO said the Swiss skincare firm plans to expand its product range at some point but would remain cautious not to lose its focus, speaking in an interview with Swiss newspaper Finanz und Wirtschaft published on Friday. • CEO Flemming Ornskov said he would favour bolt-o

· SRN Health
Galderma mindful of focus while eyeing product range expansion, CEO tells FuW
health

Jana urges Cooper to replace CEO, explore asset sales after performance setbacks

Sept 18 (Reuters) – Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighed on the medical device maker’s market value. Cooper had lowered its annual foreca

· SRN Health
health

Zealand Pharma’s short bowel syndrome drug wins backing from EU panel

Sept 18 (Reuters) – Zealand Pharma received a positive opinion from the Committee for Medicinal Products for Human Use recommending approval of its drug candidate Zeydovio for the treatment of short bowel syndrome, the Danish company said on Friday. The positive opinion marks the first major advance

· SRN Health
Zealand Pharma’s short bowel syndrome drug wins backing from EU panel
health

Researchers find genetic answer to lung cancer in those who never smoked

By Nancy Lapid Sept 18 (Reuters) – Today we feature an important genetic discovery that could help identify never-smokers at high risk of developing lung cancer. We also report on a study that aimed to make a common gynecological procedure less painful. GENE VARIANT HELPS PREDICT LUNG CANCER IN NON-

· SRN Health
health

WHO flags growing health workforce gap as workers and patients age

GENEVA, Sept 18 (Reuters) – The World Health Organization warned on Friday of a gap in the medical workforce around the world in the 2030s, with a quarter of doctors set to retire in the next decade. “In many countries both our populations and health workers are ageing at the same time. This can int

· SRN Health
WHO flags growing health workforce gap as workers and patients age
health

Tokyo court blocks Toho poison pill in test of anti-activist defences

By Makiko Yamazaki TOKYO, Sept 18 (Reuters) – A Tokyo court blocked on Friday drug wholesaler Toho Holdings’ takeover defence against an activist shareholder, in a closely watched case as Japanese companies increasingly turn to ‘poison pill’ strategies against activist investors. The Tokyo District

· SRN Health
health

Dr Reddy’s signs India distribution deal for Takeda’s Qdenga dengue vaccine

Sept 18 (Reuters) – Dr Reddy’s Laboratories said on Friday it had signed an agreement with Japanese drugmaker Takeda Pharmaceutical to promote and distribute the Qdenga dengue vaccine in India. The deal comes months after India’s drug regulator approved Qdenga for use in both children and adults, ma

· SRN Health
Dr Reddy’s signs India distribution deal for Takeda’s Qdenga dengue vaccine
health

Pentagon to proceed with controversial testosterone testing after pause

By Gram Slattery WASHINGTON, Sept 17 (Reuters) – The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson said on Thursday, bringing back a program that many medical experts have described as unnecessary and poten

· SRN Health
Pentagon to proceed with controversial testosterone testing after pause
health

Kennedy tells anti-vaccine activists they have a friend in Trump’s White House

WASHINGTON (AP) — Health and Human Services Secretary Robert F. Kennedy Jr. gave the keynote address Thursday at a conference of an anti-vaccine activist group he once chaired, telling the hundreds in attendance that they had a friend in President Donald Trump’s White House. It was Kennedy’s first t

· SRN Health
Kennedy tells anti-vaccine activists they have a friend in Trump’s White House
health

Xenon pauses new enrollment in depression drug trials over side-effect concerns

By Kamal Choudhury Sept 17 (Reuters) – Xenon Pharmaceuticals on Thursday said it has temporarily paused enrolling new patients in clinical studies testing its experimental drug for major and bipolar depression, following reports of mental and nervous system-related side effects. Shares of the drug d

· SRN Health
health

Ebola outbreak in Congo is still serious, African health body says

DAKAR, Sept 17 (Reuters) – The ongoing Ebola outbreak in Democratic Republic of Congo is still serious, with data indicating gaps in infection prevention and control, Africa’s top public health agency said on Thursday. • On Saturday, Congo Health Minister Samuel Roger Kamba said there were “encourag

· SRN Health
Ebola outbreak in Congo is still serious, African health body says
health

Ultragenyx sets $3.95 million price for rare disease gene therapy

By Sriparna Roy and Kamal Choudhury Sept 17 (Reuters) – Ultragenyx Pharmaceutical said on Thursday it has set a U.S. list price of $3.95 million for its newly approved gene therapy Fayuvi, launching one of the world’s most expensive drugs as a one-time treatment for a rare, fatal childhood disease.

· SRN Health
Ultragenyx sets $3.95 million price for rare disease gene therapy
health

Virbac confirms outlook as Supercharge platforms drive profit growth

Sept 17 (Reuters) – French animal health company Virbac reported higher half-year core profit on Thursday with a recurring operating profit, excluding amortization of assets due to acquisitions, rising 6.8% to 144.2 million euros ($165.50 million), compared with 135.0 million euros a year earlier. V

· SRN Health
health

US Senate panel sets hearing for Trump’s FDA pick

By Ahmed Aboulenein WASHINGTON, Sept 17 (Reuters) – The U.S. Senate health committee will hold a confirmation hearing next week for Dr. Heidi Overton, President Donald Trump’s pick to lead the embattled Food and Drug Administration, the panel said on Thursday. The hearing will take place on Septembe

· SRN Health
US Senate panel sets hearing for Trump’s FDA pick
health

Frankfurt reports third malaria death in airport-linked outbreak

FRANKFURT, Sept 17 (Reuters) – A third person has died from malaria around Frankfurt Airport in what German officials have described as an extremely rare air-traffic-related outbreak of the tropical disease. In a statement on Thursday, the city of Frankfurt said one of two infected residents of the

· SRN Health
health

AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England

LONDON, Sept 17 (Reuters) – AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has been approved for use in England’s state-run healthcare system, expanding access to a drug that has been available in Scotland since 2023. The companies said they will now seek appro

· SRN Health
AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England
health

CVS Health’s Aetna to streamline cancer treatment approvals

By Amina Niasse NEW YORK, Sept 17 (Reuters) – CVS Health’s Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment for cancer patients to only one medical prior authorization process early on, the company said on Thursday. Providers will get the insurer’s go

· SRN Health
CVS Health’s Aetna to streamline cancer treatment approvals